Methylphosphinic Acid

DB02845

small molecule experimental

Deskripsi

Struktur Molekul 2D

Berat 80.023
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

292 Data
Dipyridamole The therapeutic efficacy of Methylphosphinic Acid can be decreased when used in combination with Dipyridamole.
Procaine Methylphosphinic Acid may increase the neuromuscular blocking activities of Procaine.
Cocaine Methylphosphinic Acid may increase the neuromuscular blocking activities of Cocaine.
Trimethaphan Methylphosphinic Acid may increase the neuromuscular blocking activities of Trimethaphan.
Doxacurium Methylphosphinic Acid may increase the neuromuscular blocking activities of Doxacurium.
Chloroprocaine Methylphosphinic Acid may increase the neuromuscular blocking activities of Chloroprocaine.
Tubocurarine Methylphosphinic Acid may increase the neuromuscular blocking activities of Tubocurarine.
Ephedrine Methylphosphinic Acid may increase the neuromuscular blocking activities of Ephedrine.
Bambuterol Methylphosphinic Acid may increase the neuromuscular blocking activities of Bambuterol.
Butyrylthiocholine Methylphosphinic Acid may increase the neuromuscular blocking activities of Butyrylthiocholine.
Clevidipine Methylphosphinic Acid may increase the neuromuscular blocking activities of Clevidipine.
Sar9, Met (O2)11-Substance P Methylphosphinic Acid may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P.
Mirabegron Methylphosphinic Acid may increase the neuromuscular blocking activities of Mirabegron.
Aclidinium Methylphosphinic Acid may increase the neuromuscular blocking activities of Aclidinium.
Moxisylyte Methylphosphinic Acid may increase the neuromuscular blocking activities of Moxisylyte.
Propacetamol Methylphosphinic Acid may increase the neuromuscular blocking activities of Propacetamol.
Oxybuprocaine Methylphosphinic Acid may increase the neuromuscular blocking activities of Oxybuprocaine.
Benzonatate Methylphosphinic Acid may increase the neuromuscular blocking activities of Benzonatate.
Succinylcholine The metabolism of Succinylcholine can be decreased when combined with Methylphosphinic Acid.
Tramadol The therapeutic efficacy of Tramadol can be decreased when used in combination with Methylphosphinic Acid.
Trospium The therapeutic efficacy of Trospium can be decreased when used in combination with Methylphosphinic Acid.
Oxyphenonium The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Methylphosphinic Acid.
Butabarbital The therapeutic efficacy of Butabarbital can be decreased when used in combination with Methylphosphinic Acid.
Butalbital The therapeutic efficacy of Butalbital can be decreased when used in combination with Methylphosphinic Acid.
Benzatropine The therapeutic efficacy of Benzatropine can be decreased when used in combination with Methylphosphinic Acid.
Ziprasidone The therapeutic efficacy of Ziprasidone can be decreased when used in combination with Methylphosphinic Acid.
Disopyramide The therapeutic efficacy of Disopyramide can be decreased when used in combination with Methylphosphinic Acid.
Talbutal The therapeutic efficacy of Talbutal can be decreased when used in combination with Methylphosphinic Acid.
Pentobarbital The therapeutic efficacy of Pentobarbital can be decreased when used in combination with Methylphosphinic Acid.
Amitriptyline The therapeutic efficacy of Amitriptyline can be decreased when used in combination with Methylphosphinic Acid.
Ipratropium The therapeutic efficacy of Ipratropium can be decreased when used in combination with Methylphosphinic Acid.
Methadone The therapeutic efficacy of Methadone can be decreased when used in combination with Methylphosphinic Acid.
Olanzapine The therapeutic efficacy of Olanzapine can be decreased when used in combination with Methylphosphinic Acid.
Metixene The therapeutic efficacy of Metixene can be decreased when used in combination with Methylphosphinic Acid.
Terfenadine The therapeutic efficacy of Terfenadine can be decreased when used in combination with Methylphosphinic Acid.
Buclizine The therapeutic efficacy of Buclizine can be decreased when used in combination with Methylphosphinic Acid.
Clozapine The therapeutic efficacy of Clozapine can be decreased when used in combination with Methylphosphinic Acid.
Doxylamine The therapeutic efficacy of Doxylamine can be decreased when used in combination with Methylphosphinic Acid.
Trihexyphenidyl The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Methylphosphinic Acid.
Oxyphencyclimine The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Methylphosphinic Acid.
Procyclidine The therapeutic efficacy of Procyclidine can be decreased when used in combination with Methylphosphinic Acid.
Profenamine The therapeutic efficacy of Profenamine can be decreased when used in combination with Methylphosphinic Acid.
Secobarbital The therapeutic efficacy of Secobarbital can be decreased when used in combination with Methylphosphinic Acid.
Promazine The therapeutic efficacy of Promazine can be decreased when used in combination with Methylphosphinic Acid.
Hyoscyamine The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Methylphosphinic Acid.
Cyproheptadine The therapeutic efficacy of Cyproheptadine can be decreased when used in combination with Methylphosphinic Acid.
Imipramine The therapeutic efficacy of Imipramine can be decreased when used in combination with Methylphosphinic Acid.
Methscopolamine bromide The therapeutic efficacy of Methscopolamine bromide can be decreased when used in combination with Methylphosphinic Acid.
Metharbital The therapeutic efficacy of Metharbital can be decreased when used in combination with Methylphosphinic Acid.
Fluoxetine The therapeutic efficacy of Fluoxetine can be decreased when used in combination with Methylphosphinic Acid.
Chlorpromazine The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Methylphosphinic Acid.
Darifenacin The therapeutic efficacy of Darifenacin can be decreased when used in combination with Methylphosphinic Acid.
Tridihexethyl The therapeutic efficacy of Tridihexethyl can be decreased when used in combination with Methylphosphinic Acid.
Triflupromazine The therapeutic efficacy of Triflupromazine can be decreased when used in combination with Methylphosphinic Acid.
Dextromethorphan The therapeutic efficacy of Dextromethorphan can be decreased when used in combination with Methylphosphinic Acid.
Anisotropine methylbromide The therapeutic efficacy of Anisotropine methylbromide can be decreased when used in combination with Methylphosphinic Acid.
Nortriptyline The therapeutic efficacy of Nortriptyline can be decreased when used in combination with Methylphosphinic Acid.
Amoxapine The therapeutic efficacy of Amoxapine can be decreased when used in combination with Methylphosphinic Acid.
Atropine The therapeutic efficacy of Atropine can be decreased when used in combination with Methylphosphinic Acid.
Thiopental The therapeutic efficacy of Thiopental can be decreased when used in combination with Methylphosphinic Acid.
Nicardipine The therapeutic efficacy of Nicardipine can be decreased when used in combination with Methylphosphinic Acid.
Mecamylamine The therapeutic efficacy of Mecamylamine can be decreased when used in combination with Methylphosphinic Acid.
Pirenzepine The therapeutic efficacy of Pirenzepine can be decreased when used in combination with Methylphosphinic Acid.
Paroxetine The therapeutic efficacy of Paroxetine can be decreased when used in combination with Methylphosphinic Acid.
Homatropine methylbromide The therapeutic efficacy of Homatropine methylbromide can be decreased when used in combination with Methylphosphinic Acid.
Scopolamine The therapeutic efficacy of Scopolamine can be decreased when used in combination with Methylphosphinic Acid.
Isoflurane The therapeutic efficacy of Isoflurane can be decreased when used in combination with Methylphosphinic Acid.
Benzquinamide The therapeutic efficacy of Benzquinamide can be decreased when used in combination with Methylphosphinic Acid.
Clidinium The therapeutic efficacy of Clidinium can be decreased when used in combination with Methylphosphinic Acid.
Propiomazine The therapeutic efficacy of Propiomazine can be decreased when used in combination with Methylphosphinic Acid.
Propantheline The therapeutic efficacy of Propantheline can be decreased when used in combination with Methylphosphinic Acid.
Primidone The therapeutic efficacy of Primidone can be decreased when used in combination with Methylphosphinic Acid.
Dicyclomine The therapeutic efficacy of Dicyclomine can be decreased when used in combination with Methylphosphinic Acid.
Biperiden The therapeutic efficacy of Biperiden can be decreased when used in combination with Methylphosphinic Acid.
Brompheniramine The therapeutic efficacy of Brompheniramine can be decreased when used in combination with Methylphosphinic Acid.
Methylphenobarbital The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Methylphosphinic Acid.
Quinidine The therapeutic efficacy of Quinidine can be decreased when used in combination with Methylphosphinic Acid.
Amantadine The therapeutic efficacy of Amantadine can be decreased when used in combination with Methylphosphinic Acid.
Maprotiline The therapeutic efficacy of Maprotiline can be decreased when used in combination with Methylphosphinic Acid.
Methantheline The therapeutic efficacy of Methantheline can be decreased when used in combination with Methylphosphinic Acid.
Hexafluronium The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Methylphosphinic Acid.
Cycrimine The therapeutic efficacy of Cycrimine can be decreased when used in combination with Methylphosphinic Acid.
Desloratadine The therapeutic efficacy of Desloratadine can be decreased when used in combination with Methylphosphinic Acid.
Glycopyrronium The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Methylphosphinic Acid.
Tolterodine The therapeutic efficacy of Tolterodine can be decreased when used in combination with Methylphosphinic Acid.
Oxybutynin The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Methylphosphinic Acid.
Promethazine The therapeutic efficacy of Promethazine can be decreased when used in combination with Methylphosphinic Acid.
Diphenhydramine The therapeutic efficacy of Diphenhydramine can be decreased when used in combination with Methylphosphinic Acid.
Pentolinium The therapeutic efficacy of Pentolinium can be decreased when used in combination with Methylphosphinic Acid.
Doxepin The therapeutic efficacy of Doxepin can be decreased when used in combination with Methylphosphinic Acid.
Flavoxate The therapeutic efficacy of Flavoxate can be decreased when used in combination with Methylphosphinic Acid.
Desipramine The therapeutic efficacy of Desipramine can be decreased when used in combination with Methylphosphinic Acid.
Orphenadrine The therapeutic efficacy of Orphenadrine can be decreased when used in combination with Methylphosphinic Acid.
Phenobarbital The therapeutic efficacy of Phenobarbital can be decreased when used in combination with Methylphosphinic Acid.
Escitalopram The therapeutic efficacy of Escitalopram can be decreased when used in combination with Methylphosphinic Acid.
Quetiapine The therapeutic efficacy of Quetiapine can be decreased when used in combination with Methylphosphinic Acid.
Levacetylmethadol The therapeutic efficacy of Levacetylmethadol can be decreased when used in combination with Methylphosphinic Acid.
Diphenidol The therapeutic efficacy of Diphenidol can be decreased when used in combination with Methylphosphinic Acid.
Aripiprazole The therapeutic efficacy of Aripiprazole can be decreased when used in combination with Methylphosphinic Acid.
Chlorprothixene The therapeutic efficacy of Chlorprothixene can be decreased when used in combination with Methylphosphinic Acid.

Target Protein

Acetylcholinesterase ACHE
Cholinesterase BCHE
Esterase estA

Referensi & Sumber

Synthesis reference: Hans-Jerg Kleiner, "Process for the preparation of halo-methylphosphinic acid halides." U.S. Patent US3943170, issued October, 1965.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul